PHLDA1 and endometrial cancer: These findings were recapitulated in two FGFR2-driven endometrial cancer cell lines resistant to the FGFR inhibitor AZD4547 (Figure S2), signifying that this mechanism of PHLDA1 regulation in RTKi resistance is not limited to breast cancer.